OA04-05. Safety and viral load changes in HIV-1 infected subjects treated with autologous dendritic immune therapy following ART discontinuation (CTN#239)

Address: 1McGill University and INSERM Unit 743, Montreal, Canada, 2McGill University health Centre, Montreal, Canada, 3Maple Leaf Clinic, Toronto, Canada, 4Clinique Medicale l'Actuel, Montreal, Canada, 5Centre de recherche du centre Hospitalier de l'Universite de Montreal, Montreal, Canada, 6Ottawa General Hospital, Ottawa, Canada, 7Southern Alberta Clinic, Calgary, Canada, 8Medical du Quartier Latin, Montreal, Canada, 9Hamilton Health Sciences, McMaster University Medical Center, Hamilton, Canada, 10Argos Therapeutics Inc, Durham, NC, USA and 11University of Montreal Research Centre, and INSERM Unit 743, Montreal, Canada * Corresponding author